CorMedix Inc
Healthcare · EUR · F
Price
€6.743
Cap
€621.26M
Earnings
—
30d Trend
+4.1%
47% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 55×Macro 0.99 (−1%)=54
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Short-term opportunity — technical setup
BRAIN47'S ASSESSMENT
I rate CorMedix Inc at 54/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is fundamentals at 86/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
+11.8%
3 MONTHS
+18.7%
12 MONTHS
-31.9%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Short-term opportunity — technical setup. Fundamentals (86) and Quality (80) are the primary strengths. I note that momentum is the weakest area at 12/100 — this warrants monitoring. Historical volatility is elevated at 47%. I classify this as a speculative position — elevated volatility at 47% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.